Short Interest in Croda International PLC Unsponsored ADR (OTCMKTS:COIHY) Drops By 89.5%

Croda International PLC Unsponsored ADR (OTCMKTS:COIHY) saw a large drop in short interest in May. As of May 15th, there was short interest totaling 1,749 shares, a drop of 89.5% from the April 30th total of 16,585 shares. Based on an average daily volume of 14,381 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the shares of the company are sold short.

Analysts Set New Price Targets

A number of brokerages recently commented on COIHY. Kepler Capital Markets upgraded Croda International from a “reduce” rating to a “hold” rating in a research note on Tuesday, March 31st. Zacks Research downgraded shares of Croda International from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 28th. One analyst has rated the stock with a Strong Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold”.

Croda International Price Performance

Shares of OTCMKTS COIHY remained flat at $20.27 during midday trading on Thursday. The stock had a trading volume of 1,868 shares, compared to its average volume of 5,961. Croda International has a one year low of $16.26 and a one year high of $22.29. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.18 and a current ratio of 1.99. The stock has a fifty day simple moving average of $19.25 and a 200-day simple moving average of $19.01.

Croda International Company Profile

Croda International plc is a UK-based specialty chemicals company headquartered in East Yorkshire, England. Established in 1925, Croda has built a global reputation for developing and manufacturing high-performance ingredients derived primarily from natural oils and renewable resources. The company’s research-driven approach has enabled it to innovate across a wide range of sectors, delivering solutions that combine efficacy, sustainability and compliance with stringent regulatory standards.

Croda’s operations are organized around three core segments: Personal Care, Life Sciences and Performance Technologies.